Heska Corp. (HSKA) Starts Presentation at B. Riley Conference
Heska (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty health care products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, for canine and feline use, Point of Care Laboratory testing instruments and consumables, digital imaging products, software and services, allergy testing and immunotherapy, and in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, for herd animal health, private label vaccine and pharmaceutical production under third-party agreements and channels. For more…







